Back to DNTH

SILVERARC CAPITAL MANAGEMENT, LLC → DNTH

SILVERARC CAPITAL MANAGEMENT, LLC DNTH Position History

Dianthus Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$20.8M
Q3 2026
Peak value
$54.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$30.9M
Q1 2026$54.9M
Q2 2026$38M
Q3 2026$20.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$20.8M236.6K——
Q2 2026$38M390.0K——
Q1 2026$54.9M654.7K——
Q4 2025$30.9M750.1K——

Other funds holding DNTH

Other SILVERARC CAPITAL MANAGEMENT, LLC positions

KOD

KODIAK SCIENCES INC

$71.1M
CELC

CELCUITY INC

$63.9M
KALU

KALVISTA PHARMACEUTICALS INC

$57.9M
AAVXF

ABIVAX SA

$56.9M
ASND

ASCENDIS PHARMA A/S

$55M
CELC

CELCUITY INC

$52.4M
COGT

COGENT BIOSCIENCES INC

$50.6M
COGT

COGENT BIOSCIENCES INC

$50.4M